Drug recall · August 17, 2022
Lamotrigine Tablets recall
Why: Labeling: Label Error on Declared Strength
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Lamotrigine Tablets, USP 100 mg, 1000-count bottles, Rx Only, Manufactured for: AvKARE, Inc. Pulaski, TN 38478, NDC 42291-367-10, UPC 3 42291 36710 4
- Lots / codes
Lot #: 42581 Exp. 12/2024; 42484 Exp. 11/2024; 41204 Exp. 05/2024; 38723 Exp. 02/2023; 37623 Exp. 10/2022
- Quantity
- 8328 bottles
- Company
- AVKARE Inc., Pulaski, TN
- Distribution
- Nationwide within the United States
- Initiated
- July 20, 2022 · Voluntary: Firm initiated
- Classified
- August 8, 2022
- Reported
- August 17, 2022
- Ended
- September 30, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lamotrigine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.